/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

LUCID DIAGNOSTICS INC. Share Price Today: Live Updates & Key Insights

LUCID DIAGNOSTICS INC. share price today is $1.27, up -2.34%. The stock opened at $1.265 against the previous close of $1.28, with an intraday high of $1.27 and low of $1.22.

LUCID DIAGNOSTICS INC. Share Price Chart

style
pb-0

LUCID DIAGNOSTICS INC.

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

LUCID DIAGNOSTICS INC. Share Price Performance

$1.27 -0.0234(-2.34%) LUCD at 23 Mar 2026 02:10 PM Medical Devices
Lowest Today 1.22
Highest Today 1.27
Today’s Open 1.265
Prev. Close 1.28
52 Week High 1.80
52 Week Low 0.95
Day’s Range: Low 1.22 High 1.27
52-Week Range: Low 0.95 High 1.80
1 day return -
1 Week return -11.38
1 month return -13.54
3 month return +10.66
6 month return +15.27
1 year return -16.44
3 year return -15.59
5 year return -89.77
10 year return -

LUCID DIAGNOSTICS INC. Institutional Holdings

Vanguard Group Inc 3.79

Masters Capital Management LLC 3.05

BlackRock Inc 2.80

Aberdeen Group PLC 2.64

abrdn Healthcare Opportunities 2.64

Vanguard Total Stock Mkt Idx Inv 2.31

Two Seas Capital LP 2.29

Ghisallo Capital Management LLC 2.26

iShares Russell 2000 ETF 1.66

Geode Capital Management, LLC 1.55

Perkins Capital Management Inc 0.86

Vanguard Institutional Extnd Mkt Idx Tr 0.84

State Street Corp 0.78

Fidelity Small Cap Index 0.66

Renaissance Technologies Corp 0.63

Wells Fargo & Co 0.54

The Goldman Sachs Group Inc 0.43

Northern Trust Corp 0.38

Fidelity Extended Market Index 0.38

iShares Russell 2000 Value ETF 0.33

Vanguard Russell 2000 ETF 0.33

State St Russell Sm/Mid Cp® Indx SL Cl I 0.30

Sunbelt Securities 0.29

Lido Advisors, LLC 0.29

Luminus Management, LLC 0.28

Jane Street Group LLC 0.28

iShares Russell 2000 Growth ETF 0.28

Squarepoint Ops LLC 0.26

First Manhattan Co. LLC 0.25

Russell Inv Small Cap Fund F 0.24

State St Russell Sm Cap® Indx SL Cl I 0.18

Russell Inv US Small Cap Equity Y 0.18

iShares Micro-Cap ETF 0.18

Charles Schwab Investment Management Inc 0.17

Schwab Small Cap Index 0.17

NT R2000 Index Fund - NL 0.16

Blackrock Extended Mkt Fund CF 0.14

Fidelity Total Market Index 0.13

NT R2000 Index Fund - DC - NL - 3 0.13

Extended Equity Market Fund K 0.12

LUCID DIAGNOSTICS INC. Market Status

Strong Buy: 4

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

LUCID DIAGNOSTICS INC. Fundamentals

Market Cap 163.87 M

PB Ratio 2.159

PE Ratio 0.0

Enterprise Value 195.15 M

Total Assets 30.72 M

Volume 748897

LUCID DIAGNOSTICS INC. Company Financials

Annual Revenue FY23:1500000 1.5M, FY22:377000 0.4M, FY21:500000 0.5M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:-4640000 -4.6M, FY22:-3237000 -3.2M, FY21:-85000 -0.1M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-56764000 -56.8M, FY22:-56171000 -56.2M, FY21:-28737000 -28.7M, FY20:-8279517 -8.3M, FY19:-4420544 -4.4M

Quarterly Revenue Q3/2025:1211000 1.2M, Q2/2025:1163000 1.2M, Q1/2025:828000 0.8M, Q3/2024:1172000 1.2M, Q2/2024:976000 1.0M

Quarterly Profit Q3/2025:-706000 -0.7M, Q2/2025:-622000 -0.6M, Q1/2025:-723000 -0.7M, Q3/2024:-512000 -0.5M, Q2/2024:-867000 -0.9M

Quarterly Net worth Q3/2025:-10397000 -10.4M, Q2/2025:-4439000 -4.4M, Q1/2025:-26908000 -26.9M, Q3/2024:-12371000 -12.4M, Q2/2024:-11005000 -11.0M

About LUCID DIAGNOSTICS INC. & investment objective

Company Information Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. operates as a subsidiary of PAVmed Inc.

Organisation Medical Devices

Employees 72

Industry Medical Devices

CEO Dr. Lishan Aklog M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

LUCID DIAGNOSTICS INC. FAQs

What is the share price of LUCID DIAGNOSTICS INC. today?

The current share price of LUCID DIAGNOSTICS INC. is $1.27.

Can I buy LUCID DIAGNOSTICS INC. shares in India?

Yes, Indian investors can buy LUCID DIAGNOSTICS INC. shares by opening an international trading and demat account with Motilal Oswal.

How to buy LUCID DIAGNOSTICS INC. shares in India?

You can easily invest in LUCID DIAGNOSTICS INC. shares from India by:

Can I buy fractional shares of LUCID DIAGNOSTICS INC.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of LUCID DIAGNOSTICS INC.?

LUCID DIAGNOSTICS INC. has a market cap of $163.87 M.

In which sector does LUCID DIAGNOSTICS INC. belong?

LUCID DIAGNOSTICS INC. operates in the Medical Devices sector.

What documents are required to invest in LUCID DIAGNOSTICS INC. stocks?

To invest, you typically need:

What is the PE and PB ratio of LUCID DIAGNOSTICS INC.?

The PE ratio of LUCID DIAGNOSTICS INC. is N/A and the PB ratio is 2.16.